Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor
Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor
Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor
Submitted by
admin
on March 26, 2017 - 12:00pm
Source:
BioPharma Dive
News Tags:
Pfizer
Merck KGaA
Bavencio
avelumab
Headline:
Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor
Do Not Allow Advertisers to Use My Personal information
